Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy were treated with lymphoblastoid alpha-interferon. All showed a striking improvement in serum aminotransferases after the start of each course of treatment.